Reglan and Burns third degree - a phase IV clinical study of FDA data
Summary:
Burns third degree is reported as a side effect among people who take Reglan (metoclopramide hydrochloride), especially for people who are female, 40-49 old, also take Arimidex, and have Breast cancer.
The phase IV clinical study analyzes which people have Burns third degree when taking Reglan. It is created by eHealthMe based on reports of 28,854 people who have side effects when taking Reglan from the FDA, and is updated regularly.
What is Reglan?
Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.
What is Burns third degree?
Burns third degree is found to be associated with 145 drugs and 269 conditions by eHealthMe. Check the latest studies of Burns third degree.
28,854 people reported to have side effects when taking Reglan.
Among them, 13 people (0.05%) have Burns third degree.

Among these 13 people:
What is the gender of people who have Burns third degree when taking Reglan? *
- female: 92.31 %
- male: 7.69 %
What is the age of people who have Burns third degree when taking Reglan? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 33.33 %
- 40-49: 66.67 %
- 50-59: 0.0 %
- 60+: 0.0 %
What are other drugs people take besides Reglan? *
- Zometa: 13 people, 100.00%
- Cipro: 13 people, 100.00%
- Vicodin: 13 people, 100.00%
- Vancomycin: 13 people, 100.00%
- Tylox: 13 people, 100.00%
- Taxol: 13 people, 100.00%
- Aredia: 13 people, 100.00%
- Peridex: 13 people, 100.00%
- Oxycontin: 13 people, 100.00%
- Arimidex: 13 people, 100.00%
What are other side effects people have besides Burns third degree? *
- Injury: 13 people, 100.00%
- Bone Formation Increased: 13 people, 100.00%
- Oral Dysaesthesia (feeling of a biting sensation): 13 people, 100.00%
- Hypophagia (reduced food intake): 13 people, 100.00%
- Pain: 13 people, 100.00%
- Pain In Jaw: 13 people, 100.00%
- Physical Disability: 13 people, 100.00%
- Fever: 13 people, 100.00%
- Polyarthritis (arthritis which involves 5 or more joints simultaneously): 13 people, 100.00%
- Jaw Fracture: 13 people, 100.00%
What are the existing conditions these people have? *
- Breast Cancer: 3 people, 23.08%
- Hypersensitivity: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Reglan and have Burns third degree?
- Check whether Burns third degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Reglan:
- Reglan (29,455 reports)
Burns third degree treatments and more:
- Burns third degree (1,335 reports)
How severe was Burns third degree and when was it recovered:
Expand to all the drugs that have ingredients of metoclopramide hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Reglan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Burns third degree:
- Burns third degree (145 drugs)
Browse all the conditions that are associated with Burns third degree:
- Burns third degree (269 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Reglan) and Reglan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Acromegaly and Vitamin D Decreased - now
- Drug interactions of Famotidine and Tri-Sprintec - 6 seconds ago
- Could Prednisone cause Type 1 Diabetes? - 6 seconds ago
- Drug interactions of Mirabegron and Piperacillin And Tazobactam - 6 seconds ago
- Could Norvasc cause Optic Ischaemic Neuropathy? - 28 seconds ago
- Could Zopiclone cause Respiratory Tract Infection? - 43 seconds ago
- Drowsiness and Upper Limb Fracture - 51 seconds ago
- Could Sitagliptin cause Lip Swelling? - 55 seconds ago
- Drug interactions of Elidel and Benicar - 57 seconds ago
- Could Sitagliptin cause Akathisia? - 58 seconds ago